Life Science Financials
| LABS Stock | 38.60 0.10 0.26% |
Operating Margin 0.5048 | Profit Margin (1.99) | EPS Estimate Current Year 0.0151 | Return On Equity (0.14) |
Life |
Please note, the imprecision that can be found in Life Science's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Life Science REIT. Check Life Science's Beneish M Score to see the likelihood of Life Science's management manipulating its earnings.
Life Science Stock Summary
Life Science competes with Hammerson PLC, Supermarket Income, DS Smith, Rolls Royce, and Bank of Georgia. Life Science is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Real Estate, Equity Real Estate Investment Trusts (REITs) |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | GB00BP5X4Q29 |
| Business Address | Central Square, Leeds, |
| Sector | Diversified REITs |
| Industry | Real Estate |
| Benchmark | Dow Jones Industrial |
| Website | www.lifesciencereit.co.uk |
| Phone | 44 20 7945 9566 |
You should never invest in Life Science without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Life Stock, because this is throwing your money away. Analyzing the key information contained in Life Science's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Life Science Key Financial Ratios
There are many critical financial ratios that Life Science's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Life Science REIT reports annually and quarterly.| Revenue | 19.94 M | ||||
| Gross Profit | 1.28 M | ||||
| EBITDA | 8.72 M | ||||
| Net Income | (21.71 M) | ||||
| Total Asset | 410.7 M |
Life Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Life Science's current stock value. Our valuation model uses many indicators to compare Life Science value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Life Science competition to find correlations between indicators driving Life Science's intrinsic value. More Info.Life Science REIT is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Life Science's earnings, one of the primary drivers of an investment's value.Life Science REIT Systematic Risk
Life Science's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Life Science volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Life Science REIT correlated with the market. If Beta is less than 0 Life Science generally moves in the opposite direction as compared to the market. If Life Science Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Life Science REIT is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Life Science is generally in the same direction as the market. If Beta > 1 Life Science moves generally in the same direction as, but more than the movement of the benchmark.
Life Science REIT Total Assets Over Time
Life Science Thematic Clasifications
Life Science REIT is part of Real Estate investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Real Estate industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
This theme covers USA Equities from Real Estate industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
| Real Estate | View |
Life Science December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Life Science help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Life Science REIT. We use our internally-developed statistical techniques to arrive at the intrinsic value of Life Science REIT based on widely used predictive technical indicators. In general, we focus on analyzing Life Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Life Science's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.08 | |||
| Information Ratio | 0.1386 | |||
| Maximum Drawdown | 13.06 | |||
| Value At Risk | (3.39) | |||
| Potential Upside | 3.7 |
Additional Tools for Life Stock Analysis
When running Life Science's price analysis, check to measure Life Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Science is operating at the current time. Most of Life Science's value examination focuses on studying past and present price action to predict the probability of Life Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Science's price. Additionally, you may evaluate how the addition of Life Science to your portfolios can decrease your overall portfolio volatility.